Proactive and included patients can help clinical trial retention.
Phase 3 trial supports Tagrisso as “standard of care” for some patients
How do we get to the point where patient centricity is at the core of clinical trials?
QuintilesIMS’s Cristina Oliva talks to pharmaphorum about her personal highlights from this year’s congress.
In the last two years, the first PD-1 checkpoint inhibitor drugs to reach patients have launched a revolution in cancer care.